Sequencing consumables market refers to the materials and products that are used in sequencing activities, based mainly in genomics and molecular biology. These materials includes reagents, enzymes, libraries, and other consumables used in sequencing DNA and RNA among other uses. As the number of applications of high-throughput sequencing increases in the health sciences, bioinformatics, and diagnostics, the market for reagents for sequencing has grown dramatically. This sector is characterized by high technological development; manufacturers are always seeking ways to improve the efficiency and reduce the costs of the methods required to improve the sequence accuracy, the time taken to complete a process and versatility in accommodating different sample types. The consumables are used by various end users which includes academic research institutions, biotechnology companies and clinical laboratories all of whom require high quality consumables to support their sequencing needs.

Protein Engineering Market can also be described as that subsegment of the biotechnology industry that deals with engineering and designing of proteins for the sake of use in different contexts of industry, healthcare, and research.

The Spatial Omics Market can be defined as the rapidly emerging field in the segment of biotechnology and life sciences, which is dedicated to the study of distribution and localization of bio-molecules including DNA, RNA, and proteins within tissue microenvironments. This field will combine information gained from omics with spatial information to give a molecular detailing of how different cellular processes are happening at various locations in tissues or organs. Spatial omics leverages state of the art imaging to contour the molecular geography of cells and tissues, and thereby offer novel perspectives on the biological milieu and conditions such as cancer, neurodegenerative diseases and the immune system.

Sanger sequence or known as chain termination method is one of the most common sequencing methods that adopted by Frederick Sanger in 1977. This one uses identity dideoxynucleotides coupled to the DNA replication process in order to sequence nucleotides. The market for Sanger sequencing is all the machinery and equipment used in the creation and implementation of Sanger sequencing as well as all the chemicals, reagents, and consumables which are associated with Sanger sequencing. A key step in genomics and associated diagnostics, Sanger sequencing is used in several branches of application, including in personalised medicine, genetic diagnostics/phylogenetic, and biotechnology to buttress agriculture.

THe biosimilar market of Humira comes to be seen as a large portion of the contemporary pharma market, stimulated by the expiration of the patent law of AbbVie’s $10bn+ blockbuster drug Humira (adalimumab) back in 2016.